SOW
KYMR icon

State of Wyoming’s Kymera Therapeutics KYMR Stock Holding History

State of Wyoming’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
+11,780
New +$1.01M 0.14% 77
2025
Q1 		– Sell
-1,120
Closed -$45.1K – 1748
2024
Q4 		$45.1K Buy
+1,120
New +$50.6K 0.01% 1464
2024
Q3 		– Sell
-4,933
Closed -$147K – 1811
2024
Q2 		$147K Buy
+4,933
New +$171K 0.02% 793
2022
Q3 		– Sell
-203
Closed -$4K – 1738
2022
Q2 		$4K Sell
203
-952
-82% -$22.2K ﹤0.01% 1742
2022
Q1 		$49K Buy
1,155
+350
+43% +$14.8K 0.02% 1068
2021
Q4 		$51K Buy
805
+200
+33% +$11.6K 0.02% 1092
2021
Q3 		$36K Sell
605
-357
-37% -$20.7K 0.02% 845
2021
Q2 		$47K Buy
962
+555
+136% +$24.1K 0.03% 764
2021
Q1 		$16K Buy
+407
New +$24.5K 0.03% 343

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State of Wyoming's KYMR Position: Q2 2026 in Review

State of Wyoming opened a new position in Kymera Therapeutics (KYMR) in Q2 2026: 11,780 shares worth $1.35M. The stake represents 0.14% of the portfolio and ranks #77 among its holdings. This is a return to the name: State of Wyoming previously reported a position in KYMR as recently as Q4 2024.

State of Wyoming first reported a position in KYMR in Q1 2021 and has held it in 9 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • State of Wyoming held 11,780 shares of Kymera Therapeutics worth $1.35M as of Q2 2026.
  • Kymera Therapeutics was a new State of Wyoming position in Q2 2026.
  • Kymera Therapeutics made up 0.14% of State of Wyoming's portfolio in Q2 2026, its #77 holding.
  • State of Wyoming first reported a position in Kymera Therapeutics in Q1 2021 and has held it in 9 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.